Seasoned life sciences, therapeutic and functional expertise
Rigorous market research, real-world data and proprietary benchmarks
Cutting edge analytics and digital transformation solutions with clinical & commercial applications
Webinars
The Future of Patient Finding
November 13, 2024 | 1:00 – 1:45 PM ET
Two additional sessions will be offered: November 14 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai November 14 – 15:00 – 15:45 CET – Europe/Berlin Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient […]
Sign Up Now
White Papers
Moving the Needle: Lessons from the 2023 Launch Class
The 2023 launch class exceeded Trinity Life Sciences’ expectations with only 50% underperforming their pre-launch first year forecasts while 39% overperformed, indicating an improvement from prior years (54% and 35%, respectively, for 2020–2023). This was driven by notable improvements in “Specialty and Large Market” products (36% overperformed vs. 18% average in years prior) and First Launch Companies (33% overperformed vs. 20% in years prior). The needle is moving.
Read More
White Papers
2023 NRDL Pricing Implementation and Market Access Outcomes Update
The National Reimbursement Drug List (NRDL) negotiations are expected to conclude by November 2024, with pricing outcomes gradually being revealed starting in January 2025. The Trinity Life Sciences team has reviewed the 2023 NRDL inclusion and pricing results, drawing some key learnings.
Read More
